A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo

被引:218
作者
Tsai, EY
Falvo, JV
Tsytsykova, AV
Barczak, AK
Reimold, AM
Glimcher, LH
Fenton, MJ
Gordon, DC
Dunn, IF
Goldfeld, AE
机构
[1] Ctr Blood Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[5] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
关键词
D O I
10.1128/MCB.20.16.6084-6094.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor necrosis factor alpha (TNF-alpha) gene is rapidly activated by lipopolysaccharide (LPS), Here, we show that extracellular signal-regulated kinase (ERK) kinase activity but not calcineurin phosphatase activity is required for LPS-stimulated TNF-alpha gene expression, In LPS-stimulated macrophages, the ERK substrates Ets and Elk-1 bind to the TNF-alpha promoter in vivo. Strikingly, Ets and Elk-1 bind to two TNF-alpha nuclear factor of activated T cells (NFAT)-binding sites, which are required for calcineurin and NFAT-dependent TNF-alpha gene expression in lymphocytes. The transcription factors ATF-2, c-jun, Egr-1, and Sp1 are also inducibly recruited to the TNF-alpha promoter in vivo, and the binding sites for each of these activators are required for LPS-stimulated TNF-alpha gene expression. Furthermore, assembly of the LPS-stimulated TNF-alpha enhancer complex is dependent upon the coactivator proteins CREB binding protein and p300, The finding that a distinct set of transcription factors associates with a fixed set of binding sites on the TNF-alpha promoter in response to LPS stimulation lends new insights into the mechanisms by which complex patterns of gene regulation are achieved.
引用
收藏
页码:6084 / 6094
页数:11
相关论文
共 60 条
[1]  
Aggarwal B.B., 1995, HUMAN CYTOKINES THEI
[2]   ACTIVATION OF CAMP AND MITOGEN RESPONSIVE GENES RELIES ON A COMMON NUCLEAR FACTOR [J].
ARIAS, J ;
ALBERTS, AS ;
BRINDLE, P ;
CLARET, FX ;
SMEAL, T ;
KARIN, M ;
FERAMISCO, J ;
MONTMINY, M .
NATURE, 1994, 370 (6486) :226-229
[3]  
Baldassare JJ, 1999, J IMMUNOL, V162, P5367
[4]   Cooperation of Spl and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation [J].
Billon, N ;
Carlisi, D ;
Datto, MB ;
van Grunsven, LA ;
Watt, A ;
Wang, XF ;
Rudkin, BB .
ONCOGENE, 1999, 18 (18) :2872-2882
[5]   1-substituted 4-aryl-5-pyridinylimidazoles: A new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency [J].
Boehm, JC ;
Smietana, JM ;
Sorenson, ME ;
Garigipati, RS ;
Gallagher, TF ;
Sheldrake, PL ;
Bradbeer, J ;
Badger, AM ;
Laydon, JT ;
Lee, JC ;
Hillegass, LM ;
Griswold, DE ;
Breton, JJ ;
ChabotFletcher, MC ;
Adams, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) :3929-3937
[6]   Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2-and p38 mitogen-activated protein kinase-dependent TNF-α gene expression [J].
Brinkman, BMN ;
Telliez, JB ;
Schievella, AR ;
Lin, LL ;
Goldfeld, AE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30882-30886
[7]   The enhanceosome and transcriptional synergy [J].
Carey, M .
CELL, 1998, 92 (01) :5-8
[8]   CBP: A signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV [J].
Chawla, S ;
Hardingham, GE ;
Quinn, DR ;
Bading, H .
SCIENCE, 1998, 281 (5382) :1505-1509
[9]   PHOSPHORYLATED CREB BINDS SPECIFICALLY TO THE NUCLEAR-PROTEIN CBP [J].
CHRIVIA, JC ;
KWOK, RPS ;
LAMB, N ;
HAGIWARA, M ;
MONTMINY, MR ;
GOODMAN, RH .
NATURE, 1993, 365 (6449) :855-859
[10]   HETEROGENEITY OF HEMATOPOIETIC-CELLS IMMORTALIZED BY V-MYC V-RAF RECOMBINANT RETROVIRUS INFECTION OF BONE-MARROW OR FETAL LIVER [J].
COX, GW ;
MATHIESON, BJ ;
GANDINO, L ;
BLASI, E ;
RADZIOCH, D ;
VARESIO, L .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) :1492-1496